تولید مواد اولیه داروپخش
دتماد | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 59,920 2.99
Close Price: 59,890
Cash Flow
AGM
Interim
2026/05/16 Fiscal Year 2026/03/2012 Month | 2026/05/12 Fiscal Year 2026/03/2012 Month / Audited | ||
|---|---|---|---|
Cash Generated from Operations | 4.311 Trillion | 4.311 Trillion | |
Income Taxes Paid | -1.108 Trillion | -1.108 Trillion | |
Net Cash Flow from Operating Activities | 3.202 Trillion | 3.202 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 15.209 Billion | 15.209 Billion | |
Purchases of Property, Plant and Equipment | -621.801 Billion | -621.801 Billion | |
Purchases of Intangible Assets | -134.676 Billion | -134.676 Billion | |
Cash Paid to Acquire Long-Term Investments | -275 Million | -398 Million | |
Proceeds from Sale of Short-Term Investments | 73 Billion | - | |
Cash Paid to Acquire Short-Term Investments | -56 Billion | - | |
Dividends Received | - | 387 Million | |
Cash Received from Income on Other Investments | 5.921 Billion | 5.657 Billion | |
Net Cash Flow from Investing Activities | -718.622 Billion | -735.622 Billion | |
Net Cash Flow before Financing Activities | 2.484 Trillion | 2.467 Trillion | |
Cash Received from Borrowings | 8.128 Trillion | 8.145 Trillion | |
Repayments of Borrowings (Principal) | -7.075 Trillion | -7.075 Trillion | |
Interest Paid on Borrowings | -907.187 Billion | -907.187 Billion | |
Dividends Paid | -1.9 Trillion | -1.9 Trillion | |
Net Cash Flow from Financing Activities | -1.754 Trillion | -1.737 Trillion | |
Net Increase (Decrease) in Cash | 729.844 Billion | 729.844 Billion | |
Cash at Beginning of Period | 2.446 Trillion | 2.446 Trillion | |
Cash at End of Period | 2.446 Trillion | 2.446 Trillion | |
Non-Cash Transactions | 1.115 Trillion | 1.115 Trillion |